Erst- und Seniorautorenschaften
Re: First-in-human Evaluation of a Prostate-specific Membrane Antigen-targeted Near-infrared Fluorescent Small Molecule for Fluorescence-based Identification of Prostate Cancer in Patients with High-risk Prostate Cancer Undergoing Robotic-assisted Prostatectomy.
Eur Urol. 2024 Jun;85(6):588-589 Burger M.
Ureteroplasty with buccal mucosa graft without omental wrap: an effective method to treat ureteral strictures.
World J Urol. 2024 Mar 4;42(1):116 Engelmann SU, Yang Y, Pickl C, Haas M, Goßler C, Kälble S, Hartmann V, Breyer J, Burger M, Mayr R.
Long-Term Follow-Up of Peritoneal Interposition Flap in Symptomatic Lymphocele Reduction following Robot-Assisted Radical Prostatectomy: Insights from the PIANOFORTE Trial.
Cancers (Basel). 2024 May 19;16(10):1932 Goßler C, May M, Weikert S, Lenart S, Ponholzer A, Dreissig C, Stojanoski G, Anzinger I, Riester J, Burger M, Gilfrich C, Mayr R, Bründl J.
Simultaneous Isolation and Amplification of mRNA and Genomic DNA of a Single Cell.
Mol Biol. 2024;2752:71-100 Gužvić M.
A novel grading approach predicts worse outcomes in stage pT1 non-muscle-invasive bladder cancer.
BJU Int. 2024 Aug;134(2):249-257 Haas M, Engelmann SU, Mayr R, Gossler C, Pickl C, Kälble S, Yang Y, Otto W, Hartmann V, Burger M, Hartmann A, Breyer J, Eckstein M.
Improving detection of carcinoma in situ in bladder cancer: urinary cytology vs the Xpert BC Monitor.
BJU Int. 2024 Nov;134(5):755-762 Haas M, Kriegmair MC, Breyer J, Sikic D, Wezel F, Roghmann F, Brehmer M, Wirtz RM, Jarczyk J, Erben P, Bahlinger V, Goldschmidt F, Fechner G, Chen J, Paxinos E, Bates M, Zengerling F, Bolenz C, Burger M, Hartmann A, Eckstein M.
[The metastatic and advanced upper tract urothelial carcinoma-a separate entity or bladder cancer's younger sibling?]
Urologie. 2024 Oct;63(10):1011-1018 Haas M, Bahlinger V, Burger M, Bolenz C, Ma Y.
Impact of sarcopenia and fat distribution on outcomes in penile cancer.
Sci Rep. 2024 Oct 25;14(1):25422 Hartmann V, Engelmann SU, Pickl C, Haas M, Kälble S, Goßler C, Eckl C, Hofmann A, Pichler R, Burger M, Mayr R.
Agony of Choice: Caudal Block versus Ilioinguinal/Iliohypogastric Nerve Block in Unilateral Orchidopexy.
Children (Basel). 2024 Jun 29;11(7):800 Hofmann A, Koller B, Vauth F, Zöhrer PI, Badelt G, Rösch WH.
Ureterocystoplasty in Boys with Valve Bladder Syndrome-Is This Method Still up to Date?
Children (Basel). 2023 Apr 6;10(4):692 Hofmann A, Ioannou A, Zöhrer PI, Rösch WH.
Diagnoses and Treatment Recommendations-Interrater Reliability of Uroflowmetry in People with Multiple Sclerosis.
Biomedicines. 2024 Jul 18;12(7):1598 Jaekel AK, Rieger J, Butscher AL, Möhr S, Schindler O, Queissert F, Hofmann A, Schmidt P, Kirschner-Hermanns R, Knüpfer SC.
Navigating Life with Posterior Urethral Valves-Sexual Health and Lower Urinary Tract Symptoms.
J Clin Med. 2024 Jul 26;13(15):4380 Zöhrer PI, Vauth F, Jaekel AK, Rösch WH, Hofmann A.
Publication of patient series, particularly on rare tumors such as penile cancer, necessitates the contextualization of presented data with guideline recommendations.
Int J Urol. 2024 Jul;31(7):838-839 May M, Lebentrau S, Wolff I.
Real-world performance of Uromonitor in urothelial bladder cancer detection: a multicentric trial.
BJU Int. 2024 Dec;134(6):992-1000 Wolff I, Kravchuk AP, Wirtz RM, Schlomm T, Rabien A, Rong D, Hofbauer SL, Labonté FK, Barski D, Otto T, Gössl A, Brookman-May SD, Gilfrich CP, Ecke TH, May M.
Do additional nomograms based on the SEER dataset truly enhance survival prediction for patients with penile cancer?
Cancer Med. 2024 Aug;13(15):e70091 May M, Kravchuk A, Albersen M, Wolff I.
Comment on: Phallus preservation and reconstruction: 5-Year outcomes of national penile cancer centralisation in the Republic of Ireland.
2024 Oct;22(5):e186-e187 May M, Lebentrau S, Spiess PE.
Prostate-specific membrane antigen-radioguided surgery salvage lymph node dissection: experience with fifty oligorecurrent prostate cancer patients.
World J Urol. 2024 Aug 12;42(1):483 Mayr R, Engelmann SU, Yang Y, Haas M, Schmid T, Schnabel MJ, Breyer J, Schmidt D, Eiber M, Denzinger S, Burger M, Hellwig D, Moosbauer J, Grosse J
Complex Ureteral Reconstruction via Open or Robotic Ureteroplasty with a Buccal Mucosa Onlay Graft: A Two-center Comparison.
Eur Urol Open Sci. 2024 Dec 17;71:125-131 Grosso AA, Di Maida F, Paganelli D, Engelmann SU, Rinderknecht E, Eckl C, Kälble S, Barskov A, Oriti R, Giudici S, Pickl C, Burger M, Mari A, Minervini A, Mayr R.
Ureterorenoscopic Stone Removal without Antibiotic Prophylaxis.
Urol Int. 2024;108(5):392-398 Müller MR, Prey EM, Spachmann PJ, Goßler C, Burger M, Schnabel MJ.
Impact of SARS-CoV-2 Pandemic on Diagnosis of Prostate Cancer.
Urol Int. 2024 Oct 3:1-9 Oppolzer IA, Schnabel MJ, Hammer S, Zilles H, Haas M, Goßler C, Müller MR, Burger M, Gierth M.
[Urology in Upper Palatinate-what archeology, historical research, and historiography reveal : Part 1: from Roman Antiquity to the late Middle Ages].
Urologie. 2024 Mar;63(3):269-277 Otto W.
Innervation pattern of the unclosed detrusor muscle in classic bladder exstrophy: a study of patients with urothelial overexpression of nerve growth factor.
Pediatr Surg Int. 2024 Mar 5;40(1):69 Promm M, Otto W, Götz S, Burger M, Müller K, Rubenwolf P, Neuhuber WL, Rösch WH.
Long-Term Orthopaedic and Radiological Outcomes of Symphysis Approximation without Osteotomy in Primary Bladder Exstrophy Repair.
Eur J Pediatr Surg. 2024 Oct 22 Promm M, Hofbauer R, Brandl R, Gossler C, Brandstetter S, Kertai M, Hofmann A, Schnabel MJ, Rösch WH
Modification and Validation of the System Causability Scale Using AI-Based Therapeutic Recommendations for Urological Cancer Patients: A Basis for the Development of a Prospective Comparative Study.
Curr Oncol. 2024 Nov 11;31(11):7061-7073 Rinderknecht E, von Winning D, Kravchuk A, Schäfer C, Schnabel MJ, Siepmann S, Mayr R, Grassinger J, Goßler C, Pohl F, Siska PJ, Zeman F, Breyer J, Schmelzer A, Gilfrich C, Brookman-May SD, Burger M, Haas M, May M.
[Guidelines in pediatric urology : Recognizing what's important].
Urologie. 2024 Feb;63(2):139-140 Rösch W, Stein R, Hirsch-Koch K.
Antibiotic Prophylaxis of Transrectal Biopsy of the Prostate: A Plea for Fosfomycin.
Urol Int. 2024 Oct 3:1-5. Spachmann PJ, Witt D, Breyer J, Denzinger S, Burger M, Vergho DC, Otto W, Schnabel MJ. Antibiotic Prophylaxis of Transrectal Biopsy of the Prostate: A Plea for Fosfomycin.
Amoxicillin/Clavulanic Acid in Transrectal Biopsy of the Prostate-An Alternative in Times of Ciprofloxacin Obsolescence and Fosfomycin Limitation?
Antibiotics (Basel). 2024 Oct 6;13(10):940 Spachmann PJ, Fischer SE, Goßler C, Denzinger S, Burger M, Breyer J, Otto W, Schnabel MJ, Bründl J, Rosenhammer B
Recurrent Cystitis in Women-A Real-World Analysis of Bacteria Spectrum and Resistance Situation for Calculated Therapy.
Therapy. Antibiotics (Basel). 2024 Sep 16;13(9):890 Spachmann PJ, Radlmaier M, Denzinger S, Burger M, Breyer J, Otto W, Schnabel MJ, Vergho D.
The Importance of Being Grade 3: A Plea for a Three-tier Hybrid Classification System for Grade in Primary Non-muscle-invasive Bladder Cancer.
Eur Urol. 2024 Nov;86(5):391-399 Beijert IJ, Hagberg O, Gårdmark T, Holmberg L, Häggström C, Johnston A, Trail M, Hamid S, Dreyer BA, Padovani L, Garau R, Hasan R, Ahmad I, Hendry D, Compérat EM, Burger M, Rouprêt M, Gontero P, Ribal MJ, van der Kwast TH, Babjuk M, Sylvester RJ, Mariappan P, Liedberg F, van Rhijn BWG; BladderBaSe-Consortium; Scot BC Quality OPS Collaborative; Multi-center EAU Non-Muscle-Invasive Bladder Cancer Guidelines Panel Study Consortium on the WHO1973; WHO2004/2016 Classification Systems for Grade.
Multi-Center Assessment of Lymph-Node Density and Nodal-Stage to Predict Disease-Specific Survival in Patients with Bladder Cancer Treated by Radical Cystectomy.
Bladder Cancer. 2024 Jun 18;10(2):119-132 van Gennep EJ, Claps F, Bostrom PJ, Shariat SF, Neuzillet Y, Zlotta AR, Trombetta C, Eckstein M, Mertens LS, Bussani R, Burger M, Boormans JL, Wullich B, Hartmann A, Mayr R, Pavan N, Bartoletti R, Mir MC, Pouessel D, van der Hoeven J, van der Kwast TH, Allory Y, Zuiverloon TCM, Lotan Y, van Rhijn BWG.
Does Time Matter in Early Radical Cystectomy? Comparing Outcome, Clinical, and Pathological Characteristics of Immediate versus Deferred Radical Cystectomy.
Urol Int. 2024 Dec 23:1-8 Yang Y, Holbach S, Haas M, Engelmann SU, Gossler C, Mayr R, Burger M, Breyer J, Gierth M.
Co-Autorenschaften
An Empirical Survey on the Adaption of Neoadjuvant Chemotherapy in Bladder Cancer.
Urol Int. 2024;108(3):183-189 Reike MJ, Reicherz A, Tully KH, Bahlburg H, Maas M, Bach P, Klümper N, Eckstein M, Hartmann A, Breyer J, Erben P, Bolenz C, Noldus J, Berg S, Roghmann F.
High interobserver variability of PTEN immunohistochemistry defining PTEN status in low- to intermediate-risk prostate cancer: results of the first German ring trial.
Virchows Arch. 2024 Dec 9 Hommerding O, Bernhardt M, Kreft T, Scherping A, Abbas M, Baretton G, Bräsen JH, Breyer J, Darr C, Dressler FF, Ellinger J, Erber R, Esposito I, Hartmann A, Hartmann W, Heitplatz B, Kreipe H, Lafos M, Linxweiler J, Lopez-Cotarelo C, Sailer V, Reis H, Saar M, Schildhaus HU, Schlack K, Schmid M, Seidl M, Semjonow A, Sommer U, Stahl PR, Tischler V, Weber F, Wulf AL, Wullich B, Kristiansen G.
AI allows pre-screening of GFR3 mutational status using routine histology slides of muscle-invasive bladder cancer.
Nat Commun. 2024 Dec 30;15(1):10914 Bannier PA, Saillard C, Mann P, Touzot M, Maussion C, Matek C, Klümper N, Breyer J, Wirtz R, Sikic D, Schmitz-Dräger B, Wullich B, Hartmann A, Försch S, Eckstein M.
Urine-Based Biomarker Test Uromonitor() in the Detection and Disease Monitoring of Non-Muscle-Invasive Bladder Cancer-A Systematic Review and Meta-Analysis of Diagnostic Test Performance.
Cancers (Basel). 2024 Feb 11;16(4):753 Kravchuk AP, Wolff I, Gilfrich C, Wirtz RM, Soares P, Braun KP, Brookman-May SD, Kollitsch L, Hauner K, Burchardt M, Bründl J, Burger M, May M.
Evaluating the Efficacy of AI Chatbots as Tutors in Urology: A Comparative Analysis of Responses to the 2022 In-Service Assessment of the European Board of Urology.
Urol Int. 2024;108(4):359-366 May M, Körner-Riffard K, Kollitsch L, Burger M, Brookman-May SD, Rauchenwald M, Marszalek M, Eredics K.
How does artificial intelligence master urological board examinations? A comparative analysis of different Large Language Models' accuracy and reliability in the 2022 In-Service Assessment of the European Board of Urology.
World J Urol. 2024 Jan 10;42(1):20 Kollitsch L, Eredics K, Marszalek M, Rauchenwald M, Brookman-May SD, Burger M, Körner-Riffard K, May M.
Unmet Need in Non-muscle-invasive Bladder Cancer Failing Bacillus Calmette-Guérin Therapy: A Systematic Review and Cost-effectiveness Analyses from the International Bladder Cancer Group.
Eur Urol Oncol. 2025 Feb;8(1):216-229 D'Andrea D, Mostafid H, Gontero P, Shariat S, Kamat A, Masson-Lecomte A, Burger M, Rouprêt M.
Weitere Infos zu dieser Publikation
Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) in Penile Squamous Cell Carcinoma-No Evidence for a Role in Carcinogenesis.
Curr Oncol. 2024 Sep 25;31(10):5752-5761 Fiegl A, Wendler O, Giedl J, Gaisa NT, Richter G, Campean V, Burger M, Simmer F, Nagtegaal I, Wullich B, Bertz S, Hartmann A, Stoehr R.
The landscape of penile cancer research in Germany and Austria: a survey among professors in academic centers holding chair positions and results of a literature search.
World J Urol. 2024 Jan 8;42(1):12 Sarcan S, Wolff I, Lusuardi L, Kravchuk A, Wiegland J, Yakac A, Thomas C, Burger M, Gilfrich C, Lebentrau S, Ahyai S, Merseburger A, May M.
[Molecular tumor boards in uro-oncology-prostate cancer].
Urologie. 2024 Sep;63(9):899-907 Kunath F, Heidegger I, Heck M, Mayr R, Becker C, Rausch S.
Cellular liquid biopsy provides unique chances for disease monitoring, preclinical model generation and therapy adjustment in rare salivary gland cancer patients.
Mol Oncol. 2024 Oct 5 Stojanović Gužvić N, Lüke F, Treitschke S, Coluccio A, Hoffmann M, Feliciello G, Varadarajan AR, Lu X, Weidele K, Botteron C, Materna-Reichelt S, Keil F, Evert K, Weber F, Schamberger T, Althammer M, Grosse J, Hellwig D, Schulz C, Seitz S, Ugocsai P, Schlenska-Lange A, Mayr R, Kaiser U, Dietmaier W, Polzer B, Warfsmann J, Honarnejad K, Pukrop T, Heudobler D, Klein CA, Werno C.
Target trial emulation to evaluate the effect of immune-related adverse events on outcomes in metastatic urothelial cancer.
Cancer Immunol Immunother. 2024 Dec 21;74(1):30 Pichler R, Fritz J, Maier S, Hassler MR, Krauter J, D Andrea D, Laukhtina E, Gust K, Mori K, Tully KH, Niedersuess-Beke D, Korber L, Spiegelberg JA, Bauernhofer T, Subiela JD, Mayr R, Kronbichler A, Moschini M, Teoh J, Pradere B, Shariat SF, Ulmer H, Mertens LS; European Association of Urology–Young Academic Urologists (EAU-YAU): Urothelial Carcinoma Working Group.
Cabozantinib Plus Nivolumab in Adult Patients with Advanced or Metastatic Renal Cell Carcinoma: A Retrospective, Non-Interventional Study in a Real-World Cohort/GUARDIANS Project.
Cancers (Basel). 2024 Aug 28;16(17):2998 Hilser T, Darr C, Niegisch G, Schnabel MJ, Foller S, Häuser L, Zschäbitz S, Lewerich J, Ivanyi P, Schlack K, Paffenholz P, Daetwyler E, Niedersüß-Beke D, Grünwald V.
EuroGuiderm guideline on lichen sclerosus-Treatment of lichen sclerosus.
J Eur Acad Dermatol Venereol. 2024 Oct;38(10):1874-1909 Kirtschig G, Kinberger M, Kreuter A, Simpson R, Günthert A, van Hees C, Becker K, Ramakers MJ, Corazza M, Müller S, von Seitzberg S, Boffa MJ, Stein R, Barbagli G, Chi CC, Dauendorffer JN, Fischer B, Gaskins M, Hiltunen-Back E, Höfinger A, Köllmann NH, Kühn H, Larsen HK, Lazzeri M, Mendling W, Nikkels AF, Promm M, Rall KK, Regauer S, Sárdy M, Sepp N, Thune T, Tsiogka A, Vassileva S, Voswinkel L, Wölber L, Werner RN.
EuroGuiderm guideline on lichen sclerosus-introduction into lichen sclerosus.
J Eur Acad Dermatol Venereol. 2024 Oct;38(10):1850-1873. Kirtschig G, Kinberger M, Kreuter A, Simpson R, Günthert A, van Hees C, Becker K, Ramakers MJ, Corazza M, Müller S, von Seitzberg S, Boffa MJ, Stein R, Barbagli G, Chi CC, Dauendorffer JN, Fischer B, Gaskins M, Hiltunen-Back E, Höfinger A, Köllmann NH, Kühn H, Larsen HK, Lazzeri M, Mendling W, Nikkels AF, Promm M, Rall KK, Regauer S, Sárdy M, Sepp N, Thune T, Tsiogka A, Vassileva S, Voswinkel L, Wölber L, Werner RN.
Spatial relationships in the urothelial and head and neck tumor microenvironment predict response to combination immune checkpoint inhibitors.
Nat Commun. 2024 Mar 21;15(1):2538 Gil-Jimenez A, van Dijk N, Vos JL, Lubeck Y, van Montfoort ML, Peters D, Hooijberg E, Broeks A, Zuur CL, van Rhijn BWG, Vis DJ, van der Heijden MS, Wessels LFA.
Platinum-Based Chemotherapy Induces Opposing Effects on Immunotherapy Response-Related Spatial and Stromal Biomarkers in the Bladder Cancer Microenvironment.
Clin Cancer Res. 2024 Sep 13;30(18):4227-4239 Chelushkin MA, van Dorp J, van Wilpe S, Seignette IM, Mellema JJ, Alkemade M, Gil-Jimenez A, Peters D, Brugman W, Stockem CF, Hooijberg E, Broeks A, van Rhijn BWG, Mertens LS, van der Heijden AG, Mehra N, van Montfoort ML, Wessels LFA, Vis DJ, van der Heijden MS.
Consistencies in Follow-up After Radical Cystectomy for Bladder Cancer: A Framework Based on Expert Practices Collaboratively Developed by the European Association of Urology Bladder Cancer Guideline Panels.
Eur Urol Oncol. 2025 Feb;8(1):105-110 Mertens LS, Bruins HM, Contieri R, Babjuk M, Rai BP, Puig AC, Escrig JLD, Gontero P, van der Heijden AG, Liedberg F, Martini A, Masson-Lecomte A, Meijer RP, Mostafid H, Neuzillet Y, Pradere B, Redlef J, van Rhijn BWG, Rouanne M, Rouprêt M, Sæbjørnsen S, Seisen T, Shariat SF, Soria F, Soukup V, Thalmann G, Xylinas E, Mariappan P, Alfred Witjes J.
The Financial Burden of Guideline-recommended Cancer Medications for Metastatic Urothelial Carcinoma.
Eur Urol Focus. 2024 Jul;10(4):662-665 Contieri R, Martini A, Mertens LS, Giannatempo P, Hurle R, Witjes JA, Ribal MJ, van Rhijn BWG, Malavaud B.
Author Correction: High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial.
Nat Med. 2024 Jan;30(1):304 van Dorp J, Pipinikas C, Suelmann BBM, Mehra N, van Dijk N, Marsico G, van Montfoort ML, Hackinger S, Braaf LM, Amarante T, van Steenis C, McLay K, Daletzakis A, van den Broek D, van de Kamp MW, Hendricksen K, de Feijter JM, Boellaard TN, Meijer RP, van der Heijden AG, Rosenfeld N, van Rhijn BWG, Jones G, van der Heijden MS.
